|
ZC3H11A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.601600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.704600E-01 |
| Normal-vs-Stage2 |
8.268800E-01 |
| Normal-vs-Stage3 |
4.473400E-01 |
| Normal-vs-Stage4 |
8.531000E-01 |
| Stage1-vs-Stage2 |
7.781800E-01 |
| Stage1-vs-Stage3 |
9.082300E-02 |
| Stage1-vs-Stage4 |
7.951000E-01 |
| Stage2-vs-Stage3 |
4.329400E-01 |
| Stage2-vs-Stage4 |
9.863400E-01 |
| Stage3-vs-Stage4 |
4.767400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.716800E-01 |
| Normal-vs-AfricanAmerican |
2.880600E-01 |
| Normal-vs-Asian |
1.828260E-02 |
| Caucasian-vs-AfricanAmerican |
3.034400E-01 |
| Caucasian-vs-Asian |
6.770300E-02 |
| AfricanAmerican-vs-Asian |
1.088180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.617600E-01 |
| Normal-vs-Female |
2.076200E-01 |
| Male-vs-Female |
3.861500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.147400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.214400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.017600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.697800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.595000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.975800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.129000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.539200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.790200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.013800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.238200E-03 |
| Normal-vs-Grade 2 |
1.956570E-01 |
| Normal-vs-Grade 3 |
2.842800E-01 |
| Normal-vs-Grade 4 |
9.063200E-01 |
| Grade 1-vs-Grade 2 |
4.576100E-02 |
| Grade 1-vs-Grade 3 |
3.810500E-04 |
| Grade 1-vs-Grade 4 |
8.604200E-03 |
| Grade 2-vs-Grade 3 |
2.518700E-03 |
| Grade 2-vs-Grade 4 |
5.150200E-01 |
| Grade 3-vs-Grade 4 |
4.427000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.827600E-02 |
| Normal-vs-ccB subtype |
1.361170E-01 |
| ccA subtype-vs-ccB subtype |
4.00540000000671E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.663000E-01 |
| Normal-vs-N1 |
9.168000E-01 |
| N0-vs-N1 |
8.677600E-01 |
|
|
